The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1
NCT05100186
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Cataract
Interventions
DRUG:
Dexamethasone 0.4 MG [Dextenza]
Sponsor
Joseph Kavanagh, MD